Trial intelligence / Profile preview

Ketorolac for Intravenous Regional Analgesia in Lower Limb Orthopedic Surgeries

NCT05543785Recruiting

Sponsor
Mansoura University
Start
Nov 2022
Primary completion
May 2027
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of ketorolac in acute postoperative pain (2 arms), sponsored by Mansoura University. Primary endpoint: Postoperative analgesic duration at 24 hours. Started Nov 2022; status: recruiting.

02

Drugs

ketorolac
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT05543785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05543785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call